Neurodegenerative diseases and disorders represent the largest challenge to the global healthcare system. There are no objective, quantitative tools to measure brain health. Existing tests are subjective and expensive and represent "assessments" rather than objective measurements.
Why it matters
Early detection and measurement tools will allow researchers to test existing compounds and develop new compounds before symptoms become visible. We believe that the slowing down or even reversing the progression of brain diseases is possible with early treatment.
Quantitative, objective tools will allow physicians to identify early indicators, differentiate among diseases, measure and predict progression over time and differentiate patients. This will enable early detection and more precise diagnoses.
A passive, non-invasive real-time, continuous monitoring solution which measures progression over time will enable pro-active, predictive and personalized patient management.
Our Solution: A digital biomarker
NeuraMetrix measures brain health using a digital bio-marker based on inconsistency of typing cadence
no tests or special equipment
Typing cadence, NOT content
install and forget
Easy to Install
Runs in background